ビーエムジー Official site

Primate ES/iPS cell cryopreservation solution "Stem Cell Keep"

A refrigeration preservation solution suitable for epithelial, endothelial, and neural tissues that does not contain DMSO or serum proteins.

"Stem Cell Keep" is a vitrification freezing preservation solution optimized to maintain high vitrification ability while minimizing cytotoxicity, specifically designed for primate ES/iPS cells. Thanks to the high cell protection effect of a novel cryoprotectant with high safety and the ability to maintain a glassy state, it has become possible to freeze and preserve ES/iPS cell colonies more efficiently. 【Features】 - Does not contain DMSO or animal-derived protein components - Allows for freezing preservation of colonies through vitrification - Can freeze and preserve stem cells while maintaining their differentiation potential - Confirmed to be free from contamination by bacteria, fungi, and mycoplasma through sterility testing - Can be stored stably for long periods at 4°C (shelf life of 2 years) *For more details, please refer to the related links or feel free to contact us.

Related Link - http://www.bioverde.jp/%E8%A3%BD%E5%93%81%E6%83%85…

basic information

For more details, please refer to the related links or feel free to contact us.

Price range

Delivery Time

Applications/Examples of results

For more details, please refer to the related links or feel free to contact us.

BMJ Corporation Company Profile

COMPANY

Recommended products

Distributors

BMG is a research and development venture company that has been challenging the development of new biomaterial products adapted to trends in the medical field, based on a long-standing strong collaboration with the Institute for Frontier Medical Sciences at Kyoto University. Since its founding, the company has focused on the field of medical polymers to realize its corporate philosophy of "contributing to the health of people around the world by working on the development of better medical biomaterial products and providing innovative solutions in the medical field," supporting advancements in biomaterials technology and people's health across three business areas.